This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Environmental neurotoxins in Parkinson's disease

Authoring team

Efforts to understand the pathogenesis of Parkinson's disease have for four decades concentrated on the detection of environmental neurotoxins which could account for the degeneration of the substantia nigra. Particular interest has arisen since the description of Parkinsonism following administration of N-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP), a drug of abuse, by young people (1).

Exposure to certain chemicals, for example organochlorines and alkylated phosphates, has been shown to be a risk factor for Parkinson's disease (1) but the majority of cases of Parkinson's disease remain inexplicable on the basis of environmental causation.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.